Michael Scolaro

Michael Scolaro

Aug 22, 2017

Group 6 Copy 27
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can albumin from egg whites be used to treat Clostridium difficile infections?

    Clostridium difficile infection is a toxin-mediated bacterial infection responsible for 500,000 infections...

    How does involvement in kink, fetish or BDSM impact a person's health?

    Kink-involved people engage in atypical erotic activities such as bondage, rough sex, and fetish activities...

    A Modification to Homeopathic Drug Carcinosin

    Cancer is linked to genetic mutations in hosts who are already genetically unique, which can make it seem...

    Backer Badge Funded